Chinese hamster ovary (CHO) cell clustering does not correlate with in vivo histamine-sensitization when measuring residual activity of aldehyde-treated pertussis toxin (PT)

Biologicals

Volumn 30, Issue 4, 2002, Pages 297-302

  Kataoka, Michiyo ^a   Toyoizumi, Hiromi ^a   Yamamoto, Akihiko ^a   Ochiai, Masaki ^a   Horiuchi, Yoshinobu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CHO; Histamine; Pertussis; Reversion; Toxicity

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; FORMALDEHYDE; HISTAMINE; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; ASSAY; CELL ACTIVITY; CHO CELL; CONTROLLED STUDY; DETOXIFICATION; DRUG SCREENING; FEMALE; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SENSITIZATION; TEMPERATURE; TOXICITY;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0037002618     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2002.0344     Document Type: Article

References (19)

1. Kanai K. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Med Sci Biol. 33:1980;107-143.
2. Kimura M., Kuno-Sakai H. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis. Tokai J Exp Clin Med. 12:1987;263-273.
3. Preston N.W. Factors influencing the assay of the histamine-sensitizing factor of Haemophilus pertussis. J Path Bacteriol. 78:1959;217-224.
4. Ishida S., Kurokawa M., Asakawa S., Iwasa S. A sensitive assay method for the histamine-sensitizing factor using change in rectal temperature of mice after histamine challenge as a response. J Biol Stand. 7:1979;21-29.
5. The Minimum Requirements of Biological Products of Japan 1981. 1986;Ministry of Health and Welfare, Japanese Government, Tokyo.
6. Arciniega J.L., Corbel M., Dellepiane N., Dobbelaer R., Griffiths E., Heron I., Ivanoff B., Kreeftenberg H., Mastrantonio P., Meade B., Milstein J., Robertson S., Robinson A., Sato H., Sato Y., Schwanig M., Tiru M. WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. Biologicals. 26:1998;195-204.
7. The Minimum Requirements of Biological Products of Japan 1993. 1993;Ministry of Health and Welfare, Japanese Government, Tokyo.
8. Kurokawa M. Toxicity and Toxicity Testing of pertussis vaccine. Jap J med Sci Biol. 37:1984;41-81.
9. Cohen H.H. Development of pertussis vaccine production and control in the National Institute of Public Health in the Netherlands during the years 1950-1962. Antonie van Leeuwenhock. 29:1963;183-201.
10. Pittman M. Determination of the histamine sensitizing unitage of pertussis vaccine. J Biol Stand. 3:1975;185-191.
11. Stainer D.W., Scholte M.J. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 63:1971;211-220.
12. Irons L.I., MacLennan A.P. Isolation of the lymphocytosis promoting factor-hemagglutinin of Bordetella pertussis by affinity chromatography. Biochim Biophys Acta. 580:1979;175-185.
13. Reisfeld R.A., Lewis U.J., Williams D.E. Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature. 196:1962;281-283.
14. Gillenius P., Jäätmaa E., Askelöf P., Granström M., Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand. 13:1985;61-66.
15. Chazono M., Yoshida I., Konobe T., Fukai K. The purification and characterization of an acellular pertussis vaccine. J Biol Stand. 16:1988;83-89.
16. Finney D.J. Statistical Methods in Biological Assay, 2nd edn. 1964;Charles Griffin, London.
17. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Infect Dis. 1:1979;401-412.
18. Hewlett E.L., Sauer K.T., Myers G.A., Cowell J.L., Guerrant R.L. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun. 40:1983;1198-1203.
19. Kamiya H., Nii R. Overview of currently available Japanese acellular pertussis vaccines and future problems. Tokai J Exp Clin Med. 13:1988;45-49.